Pharmaceutical Biotechnology: Current Trends and Future Directions
American Journal of Pharmaceutics · 2023-10-31 · 4 (5) · 27-37
DOI: 10.71465/ajph2691 ↗At a glance
Journal article in American Journal of Pharmaceutics, published online on 2023-10-31. Written by Dr. Ayesha Khan. The full text is freely available (open access, CC BY 4.0).
Abstract (original language)
Pharmaceutical biotechnology has emerged as a transformative discipline that integrates molecular biology, genetics, and bioengineering for the development of novel therapeutics. This field has significantly contributed to the development of monoclonal antibodies, gene therapies, recombinant proteins, and mRNA-based vaccines. The current landscape is driven by advancements in synthetic biology, personalized medicine, and artificial intelligence. This paper reviews the major trends shaping pharmaceutical biotechnology today and outlines promising future directions including CRISPR gene editing, smart bioprocessing, and digital health integration. It also addresses associated regulatory, ethical, and global access challenges.
Cite
APA
Khan, D. A. (2023). Pharmaceutical Biotechnology: Current Trends and Future Directions. American Journal of Pharmaceutics, 4(5), 27-37. https://doi.org/10.71465/ajph2691
Vancouver
Khan DA. Pharmaceutical Biotechnology: Current Trends and Future Directions. American Journal of Pharmaceutics. 2023;4(5):27-37. doi:10.71465/ajph2691
BibTeX
@article{Khan2023,
author = {Khan, Dr. Ayesha},
title = {Pharmaceutical Biotechnology: Current Trends and Future Directions},
journal = {American Journal of Pharmaceutics},
year = {2023},
volume = {4},
number = {5},
pages = {27--37},
doi = {10.71465/ajph2691}
}
EUVIMED